Tag: top 5 canadian cannabis company
-
Plus Products (PLUS.C) just parachuted right into my world
Heimark has a track record of rigorous market research prior to launching products. This research-based approach has reaped dividends in market penetration and revenue growth.
-
Plus Products (PLUS.C): good deeds, good products, good numbers
“This will be the third year we have had the opportunity to partner with a local organization during pride month,” stated Mr. Heimark. “Last year we sold over 60,000 units and are looking forward to giving that record a run for its money this year.”
-
How Plus Products’ (PLUS.C) CEO Jake Heimark conquered California – and what he’s gonna do next
While the Noveau-riche cannabis bosses partied with company credit cards, Plus Products put its head down, did the researching, the strategizing, eventually building products that sold like hotcakes.
-
Yield Growth (BOSS.C): Forget the story – now we’ve got numbers
The story has always been good. “Cannabis will require an entirely new way of branding,” stated Yield Growth (BOSS.C) Penny Green in a 2018 Georgia Straight interview. “Cannabis lifestyle brands could be disruptive to several sectors, including the wellness industry, makeup, and leisure.” Green and her team set out to create cannabis-based products for lucrative…
-
1933 Industries’ (TGIF.C) blonde cannabis ain’t dumb
On October 22, 2019, 1933 Industries (TGIF.C) issued a cocky update on the launch of its “luxury brand Blonde Cannabis.” 1933 already controls 100% of Canna Hemp CBD Relief Cream which was named “Best Topical” by Leafly in 2018, and 100% of Canna Hemp X, which was named “Best Topicals for Pain” by Herb’s Guide.…
-
Khiron (KHRN.V): Why Mexican farmers are converting poppy fields to corn
I have never tried opium. But I suspect I would like it. Derived from the milky sap of the poppy, the Greek poet Homer (800 BC) referred to it as “a drug to quiet all pain and strife”. Opium provides such a delicious euphoric high, that it spawned a recreational market for synthetic opioids, including…
-
Plus Products’ (PLUS.C) Q2, 2019 financials reveal $34 million war chest and surging revenues
On August 30, 2019 Plus Products (PLUS.C) released its unaudited financial & operational results for the three and six months ended June 30, 2019, expressed in U.S. Dollars. Today, Tuesday September 3, 2019, by mid-morning, PLUS stock is up 3%. Plus Products’ Q2, 2019 revenues increased 125% Over Q2 2018 to $3.6 Million. The company’s cash…
-
GTEC Holdings (GTEC.C) puts Tumbleweed grow-op into production
On August 19, 2019 GTEC Holdings (GTEC.C) announced that its 100% owned Tumbleweed Farms has been granted a “Standard Cultivation, Processing and Medical Sales Licences, pursuant to the Cannabis Act and Regulations by Health Canada.” Tumbleweed is a purpose-built cultivation facility located in Chase, British Columbia – named after an American, Whitfield Chase, who worked…
-
Chemesis International (CSI.C) to market: “Chew on This”
On August 12, 2019 Chemesis International (CSI.C) announced that it will start manufacturing, packaging and distributing its own line of tobacco-free smokeless cannabis and hemp-derived chew in Puerto Rico and Canada and the U.S. A recent Equity Guru article described Chemesis as, “the Ichiro Suzuki of cannabis companies”. Suzuki seldom hit home runs, but was…
-
‘The Plant’ by Westleaf (WL.V) gets first cannabis derivatives contract, and it’s huge
Three weeks after we introduced The Plant by Westleaf (WL.V), the state-of-the-art production facility located in Calgary, the company secured its first major contract to supply cannabis derivatives products. Under the contract, Westleafw will supply approximately CAD$4 million worth of the good stuff to Delta 9 (NINE.V), a vertically-integrated cannabis company located in Winnipeg, Manitoba. Delta…